Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://haleemapjny323012.xzblogs.com/79297988/semaglutide-a-potential-solution-for-obesity